Tokyo, Japan, June 3, 2022 - JSR Corporation (Head Office: Minato-ku, Tokyo, Representative Director and CEO: Eric Johnson, JSR Corporation) announced today that it has concluded a facility use agreement with KINS Co., Ltd. (KINS), a company with a database of human microbiome, for the Collaborative Lab, a collaborative research facility for startups, which was established in a new research laboratory at the "JSR Bioscience and Informatics R&D Center (JSR BiRD)" in Kawasaki City, Kanagawa Prefecture last July. KINS will be the first company to use the Collaboration Lab since JSR BiRD opened.
KINS is a health technology company that supports the care of microbiome, which is responsible for health and vitality throughout the body, and accelerates research while building and analyzing databases of microbiome samples from skin, scalp, intestines, and more. The company recently expanded its business to include the microbiome of dogs and cats and plans to develop products and services to enter the pharmaceutical field.
JSR is continuing to develop its life sciences business, mainly diagnostic reagent materials, bioprocess materials, and drug discovery and development support business. At the same time, the company is engaged in research on the microbiome as a next generation technology with a focus on innovation leading to new products and services required for a healthy and long-living society. Through collaborative research with KINS, we aim to further accelerate and next generation research.
Business: Development, manufacture, sales of supplements and cosmetics, and analysis and construction of database for microbiome